Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 26 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2022 Filed Feb 17, 2022 18:46 UTC |
Wassersug MarkChief Operating Officer
|
GrantCommon Stock | 8,582 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-010996 · doc4.xml · nonDerivative · entry 3 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,533 F3 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 5, 2021. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2021 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 15, 2022, 1/3 on February 15, 2023 and 1/3 on February 15, 2024). Of the 8,582 shares, 2,861 were issued on February 15, 2022, of which 1,291 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 5,721 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 18:43 UTC |
Goone David SChief Strategic Officer
|
Tax withholdingCommon Stock | 1,996 | $125.22 | $249,939.12 |
DisclosureSEC source: 0001209191-22-010991 · doc4.xml · nonDerivative · entry 2 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,054 F2 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 174,772 shares of common stock and 27,282 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 18:43 UTC |
Goone David SChief Strategic Officer
|
GrantCommon Stock | 13,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-010991 · doc4.xml · nonDerivative · entry 1 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,050 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 5, 2021. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2021 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 15, 2022, 1/3 on February 15, 2023 and 1/3 on February 15, 2024). Of the 13,486 shares, 4,496 were issued on February 15, 2022, of which 1,996 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 8,990 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 18:48 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 8,000 | $125.22 | $1,001,760.00 |
DisclosureSEC source: 0001209191-22-011000 · doc4.xml · nonDerivative · entry 2 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,306,223 F3 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,199,566 shares of common stock and 106,657 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 18:48 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
GrantCommon Stock | 52,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011000 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,314,223 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 5, 2021. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2021 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 15, 2022, 1/3 on February 15, 2023 and 1/3 on February 15, 2024). Of the 52,718 shares, 17,573 were issued on February 15, 2022, of which 8,000 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 35,145 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. F2 · balance_after: Amount of securities beneficially owned includes 105 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2021. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:48 UTC |
Surdykowski Andrew JGeneral Counsel
|
Tax withholdingCommon Stock | 781 | $125.22 | $97,796.82 |
DisclosureSEC source: 0001209191-22-011001 · doc4.xml · nonDerivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,102 F3 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 33,365 shares of common stock and 10,737 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:48 UTC |
Surdykowski Andrew JGeneral Counsel
|
GrantCommon Stock | 6,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011001 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,883 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 5, 2021. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2021 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 15, 2022, 1/3 on February 15, 2023 and 1/3 on February 15, 2024). Of the 6,129 shares, 2,043 were issued on February 15, 2022, of which 781 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 4,086 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. F2 · balance_after: Amount of securities beneficially owned includes 105 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2021. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:45 UTC |
Martin Lynn CPresident, NYSE Group
|
Tax withholdingCommon Stock | 2,296 | $125.22 | $287,505.12 |
DisclosureSEC source: 0001209191-22-010995 · doc4.xml · nonDerivative · entry 2 Martin Lynn C · CIK 0001754817 · President, NYSE Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,524 F3 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 22,419 shares of common stock, 3,840 unvested restricted stock units ("RSUs"), and 21,265 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:45 UTC |
Martin Lynn CPresident, NYSE Group
|
GrantCommon Stock | 13,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-010995 · doc4.xml · nonDerivative · entry 1 Martin Lynn C · CIK 0001754817 · President, NYSE Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,820 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 5, 2021. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2021 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 15, 2022, 1/3 on February 15, 2023 and 1/3 on February 15, 2024). Of the 13,486 shares, 4,496 were issued on February 15, 2022, of which 2,296 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 8,990 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. F2 · balance_after: Amount of securities beneficially owned includes 105 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2021. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:44 UTC |
Jackson BenjaminPresident
|
Tax withholdingCommon Stock | 2,774 | $125.22 | $347,360.28 |
DisclosureSEC source: 0001209191-22-010993 · doc4.xml · nonDerivative · entry 2 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,304 F3 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 84,752 shares of common stock and 30,552 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:44 UTC |
Jackson BenjaminPresident
|
GrantCommon Stock | 18,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-010993 · doc4.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,078 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 5, 2021. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2021 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 15, 2022, 1/3 on February 15, 2023 and 1/3 on February 15, 2024). Of the 18,390 shares, 6,130 were issued on February 15, 2022, of which 2,774 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 12,260 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. F2 · balance_after: Amount of securities beneficially owned includes 105 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2021. Read SEC document |
| February 10, 2022 Filed Feb 17, 2022 18:46 UTC |
Wassersug MarkChief Operating Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 11,022 | $0.00 Strike: $50.01 | $0.00 |
DisclosureSEC source: 0001209191-22-010996 · doc4.xml · derivative · entry 5 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,958 Underlying: Common Stock · 11,022 shares Expires 2026-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested. Read SEC document |
| February 10, 2022 Filed Feb 17, 2022 18:46 UTC |
Wassersug MarkChief Operating Officer
|
SaleCommon Stock | 11,022 | $127.00 | $1,399,794.00 |
DisclosureSEC source: 0001209191-22-010996 · doc4.xml · nonDerivative · entry 2 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,951 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| February 10, 2022 Filed Feb 17, 2022 18:46 UTC |
Wassersug MarkChief Operating Officer
|
Exercise / conversionCommon Stock | 11,022 | $50.01 | $551,210.22 |
DisclosureSEC source: 0001209191-22-010996 · doc4.xml · nonDerivative · entry 1 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: Amount of securities beneficially owned includes 105 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2021. Read SEC document |
| February 09, 2022 Filed Feb 10, 2022 21:49 UTC |
CRISP CHARLES RDirector
|
SaleCommon Stock | 894 | $130.36 | $116,543.27 |
DisclosureSEC source: 0001209191-22-008511 · doc4.xml · nonDerivative · entry 2 CRISP CHARLES R · CIK 0001015825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,475 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $129.96 - $130.70. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 33,754 shares of common stock and 1,721 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 14, 2022. Read SEC document |
| February 09, 2022 Filed Feb 10, 2022 21:49 UTC |
CRISP CHARLES RDirector
|
SaleCommon Stock | 2,233 | $129.44 | $289,037.51 |
DisclosureSEC source: 0001209191-22-008511 · doc4.xml · nonDerivative · entry 1 CRISP CHARLES R · CIK 0001015825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,369 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $128.95 - $129.85. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 16:50 UTC |
Namkung James WChief Accounting Officer
|
Tax withholdingCommon Stock | 165 | $127.59 | $21,052.35 |
DisclosureSEC source: 0001209191-22-008514 · doc4.xml · nonDerivative · entry 1 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,456 F1 · shares: Represents shares of restricted stock issued to the filing person on February 8, 2019. The restricted stock units vest over three years (1/3 on February 8, 2020, 1/3 on February 8, 2021 and 1/3 on February 8, 2022). Of the 1,641 shares, the remaining 547 shares were issued on February 8, 2022, of which 165 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The third and final tranche of shares for this award have been issued. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 9,142 shares of common stock and 1,326 unvested restricted stock units ("RSUs"), and 4,988 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and will be reported at the time of vesting. Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 23:31 UTC |
Gardiner WarrenChief Financial Officer
|
Tax withholdingCommon Stock | 133 | $127.59 | $16,969.47 |
DisclosureSEC source: 0001209191-22-008995 · doc4.xml · nonDerivative · entry 3 Gardiner Warren · CIK 0001855007 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,748 F3 · shares: Represents shares of restricted stock issued to the filing person on February 8, 2019. The restricted stock units vest over three years (1/3 on February 8, 2020, 1/3 on February 8, 2021 and 1/3 on February 8, 2022). Of the 1,313 shares, the remaining 438 shares were issued on February 8, 2022, of which 133 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The third and final tranche of shares for this award have been issued. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 6,023 shares of common stock and 3,355 unvested restricted stock units ("RSUs"), and 5,370 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and will be reported at the time of vesting. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 17:18 UTC |
Namkung James WChief Accounting Officer
|
Tax withholdingCommon Stock | 132 | $127.68 | $16,853.76 |
DisclosureSEC source: 0001209191-22-008112 · doc4.xml · nonDerivative · entry 2 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,621 F3 · shares: Represents shares of restricted stock issued to the filing person on February 5, 2021. The restricted stock units vest over three years (1/3 on February 5, 2022, 1/3 on February 5, 2023 and 1/3 on February 5, 2024). Of the 1,313 shares, 437 shares were issued on February 7, 2022, of which 132 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 876 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 8,760 shares of common stock and 1,873 unvested restricted stock units ("RSUs"), and 4,988 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and will be reported at the time of vesting. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 17:18 UTC |
Namkung James WChief Accounting Officer
|
Tax withholdingCommon Stock | 136 | $127.68 | $17,364.48 |
DisclosureSEC source: 0001209191-22-008112 · doc4.xml · nonDerivative · entry 1 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,753 F1 · shares: Represents shares of restricted stock issued to the filing person on February 7, 2020. The restricted stock units vest over three years (1/3 on February 7, 2021, 1/3 on February 7, 2022 and 1/3 on February 7, 2023). Of the 1,349 shares, 450 shares were issued on February 7, 2022, of which 136 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 450 shares are scheduled to be issued on February 7, 2023 and taxes for this issuance will be withheld and reported at the time of vesting. F2 · balance_after: Amount of securities beneficially owned includes 105 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2021. Read SEC document |
| February 07, 2022 Filed Feb 11, 2022 23:31 UTC |
Gardiner WarrenChief Financial Officer
|
Tax withholdingCommon Stock | 133 | $127.68 | $16,981.44 |
DisclosureSEC source: 0001209191-22-008995 · doc4.xml · nonDerivative · entry 2 Gardiner Warren · CIK 0001855007 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,881 F2 · shares: Represents shares of restricted stock issued to the filing person on February 5, 2021. The restricted stock units vest over three years (1/3 on February 5, 2022, 1/3 on February 5, 2023 and 1/3 on February 5, 2024). Of the 1,313 shares, 437 shares were issued on February 7, 2022, of which 133 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 876 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. Read SEC document |
| February 07, 2022 Filed Feb 11, 2022 23:31 UTC |
Gardiner WarrenChief Financial Officer
|
Tax withholdingCommon Stock | 136 | $127.68 | $17,364.48 |
DisclosureSEC source: 0001209191-22-008995 · doc4.xml · nonDerivative · entry 1 Gardiner Warren · CIK 0001855007 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,014 F1 · shares: Represents shares of restricted stock issued to the filing person on February 7, 2020. The restricted stock units vest over three years (1/3 on February 7, 2021, 1/3 on February 7, 2022 and 1/3 on February 7, 2023). Of the 1,349 shares, 450 shares were issued on February 7, 2022, of which 136 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 450 shares are scheduled to be issued on February 7, 2023 and taxes for this issuance will be withheld and reported at the time of vesting. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 21:35 UTC |
Gardiner WarrenChief Financial Officer
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 8,869 | $0.00 Strike: $129.76 | $0.00 |
DisclosureSEC source: 0001209191-22-007759 · doc4.xml · derivative · entry 1 Gardiner Warren · CIK 0001855007 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,869 Underlying: Common Stock · 8,869 shares Expires 2032-02-04 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 4, 2023, 33.33% of the options vest on February 4, 2024 and 33.33% of the options vest on February 4, 2025. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 16:40 UTC |
Namkung James WChief Accounting Officer
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 4,257 | $0.00 Strike: $129.76 | $0.00 |
DisclosureSEC source: 0001209191-22-007764 · doc4.xml · derivative · entry 1 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,257 Underlying: Common Stock · 4,257 shares Expires 2032-02-04 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 4, 2023, 33.33% of the options vest on February 4, 2024 and 33.33% of the options vest on February 4, 2025. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 16:43 UTC |
Wassersug MarkChief Operating Officer
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 13,482 | $0.00 Strike: $129.76 | $0.00 |
DisclosureSEC source: 0001209191-22-007770 · doc4.xml · derivative · entry 1 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,482 Underlying: Common Stock · 13,482 shares Expires 2032-02-04 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 4, 2023, 33.33% of the options vest on February 4, 2024 and 33.33% of the options vest on February 4, 2025. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 16:37 UTC |
Goone David SChief Strategic Officer
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 19,513 | $0.00 Strike: $129.76 | $0.00 |
DisclosureSEC source: 0001209191-22-007760 · doc4.xml · derivative · entry 1 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,513 Underlying: Common Stock · 19,513 shares Expires 2032-02-04 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 4, 2023, 33.33% of the options vest on February 4, 2024 and 33.33% of the options vest on February 4, 2025. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 16:41 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 88,699 | $0.00 Strike: $129.76 | $0.00 |
DisclosureSEC source: 0001209191-22-007765 · doc4.xml · derivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,699 Underlying: Common Stock · 88,699 shares Expires 2032-02-04 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 4, 2023, 33.33% of the options vest on February 4, 2024 and 33.33% of the options vest on February 4, 2025. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 21:42 UTC |
Surdykowski Andrew JGeneral Counsel
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 10,643 | $0.00 Strike: $129.76 | $0.00 |
DisclosureSEC source: 0001209191-22-007768 · doc4.xml · derivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,643 Underlying: Common Stock · 10,643 shares Expires 2032-02-04 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 4, 2023, 33.33% of the options vest on February 4, 2024 and 33.33% of the options vest on February 4, 2025. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 21:39 UTC |
Martin Lynn CPresident, NYSE Group
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 19,513 | $0.00 Strike: $129.76 | $0.00 |
DisclosureSEC source: 0001209191-22-007763 · doc4.xml · derivative · entry 1 Martin Lynn C · CIK 0001754817 · President, NYSE Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,513 Underlying: Common Stock · 19,513 shares Expires 2032-02-04 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 4, 2023, 33.33% of the options vest on February 4, 2024 and 33.33% of the options vest on February 4, 2025. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 21:38 UTC |
Jackson BenjaminPresident
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 26,609 | $0.00 Strike: $129.76 | $0.00 |
DisclosureSEC source: 0001209191-22-007761 · doc4.xml · derivative · entry 1 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,609 Underlying: Common Stock · 26,609 shares Expires 2032-02-04 F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 4, 2023, 33.33% of the options vest on February 4, 2024 and 33.33% of the options vest on February 4, 2025. Read SEC document |
| December 10, 2021 Filed Dec 10, 2021 16:34 UTC |
Wassersug MarkChief Operating Officer
|
SaleCommon Stock | 1,072 | $135.20 | $144,934.40 |
DisclosureSEC source: 0001209191-21-069056 · doc4.xml · nonDerivative · entry 1 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,846 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 9,379 shares of common stock and 9,467 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 16:34 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 2,400 | $0.00 Strike: $41.59 | $0.00 |
DisclosureSEC source: 0001209191-21-069054 · doc4.xml · derivative · entry 5 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,325 Underlying: Common Stock · 2,400 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options are fully vested. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 16:34 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 14,175 | $135.12 | $1,915,310.41 |
DisclosureSEC source: 0001209191-21-069054 · doc4.xml · nonDerivative · entry 3 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,031,705 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F4 · price: The price range for the aggregate amount sold by the direct holder is $134.95 - $135.40. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 · balance_after: These shares are beneficially owned directly by Continental Power Exchange, Inc. ("CPEX"). Mr. Sprecher beneficially owns 100% of the equity interest in CPEX directly. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 16:34 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 45,825 | $134.63 | $6,169,488.49 |
DisclosureSEC source: 0001209191-21-069054 · doc4.xml · nonDerivative · entry 2 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,045,880 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $133.95 - $134.94. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 16:34 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 2,400 | $41.59 | $99,816.00 |
DisclosureSEC source: 0001209191-21-069054 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,261,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,189,888 shares of common stock and 71,512 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 17:12 UTC |
Goone David SChief Strategic Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 1,492 | $0.00 Strike: $67.00 | $0.00 |
DisclosureSEC source: 0001209191-21-068547 · doc4.xml · derivative · entry 2 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,849 Underlying: Common Stock · 1,492 shares Expires 2028-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options are fully vested. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 17:12 UTC |
Goone David SChief Strategic Officer
|
Exercise / conversionCommon Stock | 1,492 | $67.00 | $99,964.00 |
DisclosureSEC source: 0001209191-21-068547 · doc4.xml · nonDerivative · entry 1 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The common stock number referred in Table I is an aggregate number and represents 172,272 shares of common stock and 18,292 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:34 UTC |
Martin Lynn CPresident, Fixed Income & Data
|
GrantCommon Stock | 3,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-068322 · doc4.xml · nonDerivative · entry 1 Martin Lynn C · CIK 0001754817 · President, Fixed Income & Data 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,229 F1 · shares: Represents shares of restricted stock issued to the filing person on December 3, 2021. This award of restricted stock vests over three years (1/3 on each anniversary of the award date). F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 20,114 shares of common stock, 3,840 unvested restricted stock units ("RSUs"), and 12,275 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| November 23, 2021 Filed Nov 26, 2021 16:31 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
GiftCommon Stock | 67,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-066932 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,259,000 F1 · shares: This transaction involved a gift of 67,500 shares of the Issuer's common stock by the reporting person to a philanthropic organization. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,187,488 shares of common stock and 71,512 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:32 UTC |
Gardiner WarrenChief Financial Officer
|
SaleCommon Stock | 1,300 | $135.08 | $175,604.00 |
DisclosureSEC source: 0001209191-21-064200 · doc4.xml · nonDerivative · entry 1 Gardiner Warren · CIK 0001855007 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,150 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 5,100 shares of common stock and 4,680 unvested restricted stock units ("RSUs"), and 5,370 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 16:33 UTC |
Wassersug MarkChief Operating Officer
|
SaleCommon Stock | 2,000 | $135.08 | $270,160.00 |
DisclosureSEC source: 0001209191-21-064203 · doc4.xml · nonDerivative · entry 1 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,918 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 10,451 shares of common stock and 9,467 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:33 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 2,070 | $0.00 Strike: $50.01 | $0.00 |
DisclosureSEC source: 0001209191-21-064201 · doc4.xml · derivative · entry 5 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,580 Underlying: Common Stock · 2,070 shares Expires 2026-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:33 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 2,500 | $0.00 Strike: $41.59 | $0.00 |
DisclosureSEC source: 0001209191-21-064201 · doc4.xml · derivative · entry 4 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:33 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 4,500 | $135.08 | $607,860.00 |
DisclosureSEC source: 0001209191-21-064201 · doc4.xml · nonDerivative · entry 3 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,649 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 31,998 shares of common stock and 6,651 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:33 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionCommon Stock | 2,070 | $50.01 | $103,520.70 |
DisclosureSEC source: 0001209191-21-064201 · doc4.xml · nonDerivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:33 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionCommon Stock | 2,500 | $41.59 | $103,975.00 |
DisclosureSEC source: 0001209191-21-064201 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 21:32 UTC |
Jackson BenjaminPresident
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 2,770 | $0.00 Strike: $41.37 | $0.00 |
DisclosureSEC source: 0001209191-21-063860 · doc4.xml · derivative · entry 2 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,100 Underlying: Common Stock · 2,770 shares Expires 2024-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 21:32 UTC |
Jackson BenjaminPresident
|
Exercise / conversionCommon Stock | 2,770 | $41.37 | $114,594.90 |
DisclosureSEC source: 0001209191-21-063860 · doc4.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: Amount of securities beneficially owned includes 110 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2021. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 81,291 shares of common stock and 18,292 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 16:31 UTC |
Namkung James WChief Accounting Officer
|
SaleCommon Stock | 1,559 | $135.09 | $210,605.31 |
DisclosureSEC source: 0001209191-21-062413 · doc4.xml · nonDerivative · entry 1 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,784 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 8,036 shares of common stock and 2,760 unvested restricted stock units ("RSUs"), and 4,988 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:30 UTC |
Farooqui Duriya MDirector
|
SaleCommon Stock | 1,979 | $135.09 | $267,343.11 |
DisclosureSEC source: 0001209191-21-062410 · doc4.xml · nonDerivative · entry 1 Farooqui Duriya M · CIK 0001699994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,393 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 7,672 shares of common stock and 1,721 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 14, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.